Overview

Travoprost/Brinzolamide Fixed Combination Versus Travatan and Versus AZOPT

Status:
Terminated
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to compare the IOP lowering efficacy of Travoprost/Brinzolamide dosed daily in the morning or evening, vs TRAVATAN dosed once daily in the evening, and vs. AZOPT dosed BID in patients with open-angle glaucoma or ocular hypertension.
Phase:
Phase 3
Details
Lead Sponsor:
Alcon Research
Treatments:
Brinzolamide
Travoprost